The Program That's Putting Unproven Drugs on the US Market
Aduhelm, a new medication for Alzheimer’s disease.
BiogenHi, it’s Drew in New York. Today we’re going to talk about how the government pays billions of dollars a year for drugs before it knows whether they actually work. But first…
Between 2018 and 2021, US taxpayers spent $18 billion on drugs that didn’t have clear evidence of actually working.